Skip to search.
 TSX Down 0.34% TSX Ventures Down 0.60%

Geron Corporation (GERN)

-NasdaqGS
2.81 Down 0.15(5.07%) Mar 4, 4:00PM EST
|After Hours : 2.82 Up 0.01 (0.36%) Mar 4, 5:35PM EST
Add to Portfolio
Prev Close:2.96
Open:2.86
Bid:2.82 x 600
Ask:2.92 x 3000
1y Target Est:4.63
Beta:2.44
Next Earnings Date:N/A
Day's Range:2.70 - 2.92
52wk Range:1.31 - 4.54
Volume:4,432,673
Avg Vol (3m):2,785,400
Market Cap:441.76M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 5.07%441.76M
BMYUp 6.06%109.15B
GSKUp 0.23%115.03B
NVSDown 0.02%237.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):387.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.28
Quarterly EPS Est (Mar-15) :-0.07
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback